Table 2.

Properties associated with plasminogen-binding activity among emm pattern D strains

StrainemmtypeaTissue site of isolationbIsolation datePlacebPCR product (PAM primers)% of bound 125I-labeled plasminogen
13RS6033NP1941New York+≥50
A91033NP1966ND+≥50
A98233Imp1968New York+≥50
3732-S33Imp1969Alabama+≥50
6010-S33Imp1971Alabama+≥50
D73533Imp1973New York+≥50
2948733Imp1987Czech Republic+≥50
AP52c 52Imp1967Minnesota+≥50
D61752Imp1972Trinidad+≥50
AP53c 53Imp1967Minnesota+≥50
ALAB4953Imp1986Alabama+≥50
29689pt2110Imp1988Czech Republic+≥50
ALAB55pt2110Imp1986Alabama+25
D964pt2631Imp1976Trinidad+≥50
D821pt5757Imp1975Trinidad+≥50
29486st2370Imp1987Czech Republic+≥50
D432stD432ND1971Egypt+≥50
D631stD631Imp1972Trinidad+≥50
D633stD633Imp1972Trinidad+≥50
D680stD633NP1972Trinidad+≥50
D641stNS5Imp1972Trinidad+≥50
D466potter41ND1971Egypt+25
D502potter41Imp1971Trinidad+10
D99870ND1976Japan+20
10RS10132NP1942New York15
1RS7942NP1941New York10
A45736ND1961Former Yugoslavia≤5
D626st88/31Imp1972Trinidad≤5
  • a For several isolates, previous reports (5, 8) indicated M serological types that are discordant with the emm sequence types presented here.

  • b Imp, impetigo; NP, nasopharyngeal site; ND, not determined.

  • c AP52 and AP53 are also designated CV686 and CV265, respectively (31). AP53 is the strain from which Emm53 (PAM) was originally derived (4).